http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0440289-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f5033fcf56d5a13743728cc85a8dc3f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
filingDate 1991-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cdc5bc7f4bf26e70c0e4e7178b887ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7d6a78009ba82a91663426d45cfebed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_454e977ddb9ea580ab836908d5667db8
publicationDate 1991-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0440289-A1
titleOfInvention Liposome-containing intranasal vaccine formulation
abstract The present invention relates to a vaccine formulation for intranasal or inhalation administration, and to the preparation thereof, which formulation contains antigenic material freely mixed with empty liposomes.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8187585-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5942237-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2272178-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2442450-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2442450-R1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-016023-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007034022-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006078213-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1013269-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1013269-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8007806-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9417827-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4136553-A1
priorityDate 1990-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4148876-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0155625-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2066203-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0356340-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8905631-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0324455-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4395394-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0158880-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4323561-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4261975-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226446069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75143

Total number of triples: 56.